Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 7,046 | 5,988 | 6,701 | 6,996 | 7,126 |
| Operating Income | -7,046 | -5,988 | -6,701 | -6,996 | -7,126 |
| Interest Expense | 368 | 409 | 459 | 504 | 546 |
| Other Income | 104 | 157 | 58 | 54 | 156 |
| Pre-tax Income | -7,310 | -6,240 | -7,102 | -7,446 | -7,516 |
| Income Tax | -477 | N/A | -7,102 | N/A | N/A |
| Net Income Continuous | -6,833 | -13,342 | N/A | -7,446 | -7,516 |
| Net Income | $-6,833 | $-13,342 | $N/A | $-7,446 | $-7,516 |
| EPS Basic Total Ops | -400.00 | -340.00 | -440.00 | -520.00 | -520.00 |
| EPS Basic Continuous Ops | -399.25 | -790.01 | N/A | -517.05 | -522.50 |
| EPS Diluted Total Ops | -400.00 | -340.00 | -440.00 | -520.00 | -520.00 |
| EPS Diluted Continuous Ops | -399.25 | -790.01 | N/A | -517.05 | -522.50 |
| EBITDA(a) | $-7,040 | $-5,981 | $-6,696 | $-6,990 | $-7,121 |